Invasive aspergillosis - Clinical features of 35 proven cases at a single institution

被引:57
作者
Kaiser, L
Huguenin, T
Lew, PD
Chapuis, B
Pittet, D
机构
[1] Univ Hosp Geneva, Div Infect Dis, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Div Hematol, Dept Internal Med, CH-1211 Geneva 14, Switzerland
关键词
D O I
10.1097/00005792-199805000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thirty-five patients with clinical features and histologically or microbiologically proven infection met predetermined stringent criteria for invasive aspergillosis over a 5-year period at our institution. Underlying conditions included hematologic malignancy, solid tumor, bone marrow and solid organ transplantation, and immunosuppressive therapy. The majority of patients (94%) presented with respiratory symptoms and abnormal pulmonary chest radiography; only 40% had neutropenia at time of infection. Invasive aspergillosis was suspected in only 21 cases (60%). Concomitant infections were present in 83% of patients. Half of patients had pathogenic or potentially pathogenic microorganisms other than Aspergillus spp. isolated from pulmonary specimens at time of aspergillosis. Aspergillus spp. were recovered from sputum in 75% of patients and from bronchoalveolar lavage in only 52%. Invasive aspergillosis is an unexpectedly unrecognized disease with poor outcome; overall mortality was 94% in our series. The lack of sensitivity of diagnostic procedures, together with the high frequency of concomitant infections, delays the time of diagnosis. Early diagnostic tests are needed, and presumptive antifungal therapy among high-risk patients is mandatory.
引用
收藏
页码:188 / 194
页数:7
相关论文
共 50 条
[1]   INVASIVE ASPERGILLOSIS IN ACUTE-LEUKEMIA - CORRELATION WITH NOSE CULTURES AND ANTIBIOTIC USE [J].
AISNER, J ;
MURILLO, J ;
SCHIMPFF, SC ;
STEERE, AC .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) :4-9
[2]   ROLE OF FIBEROPTIC BRONCHOSCOPY IN THE DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS IN PATIENTS WITH ACUTE-LEUKEMIA [J].
ALBELDA, SM ;
TALBOT, GH ;
GERSON, SL ;
MILLER, WT ;
CASSILETH, PA .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (06) :1027-1034
[3]   OPPORTUNISTIC MYCOSES IN THE IMMUNOCOMPROMISED HOST - EXPERIENCE AT A CANCER CENTER AND REVIEW [J].
ANAISSIE, E .
CLINICAL INFECTIOUS DISEASES, 1992, 14 :S43-S53
[4]  
ARNOW PM, 1978, AM REV RESPIR DIS, V118, P49
[5]   STRATEGIES IN PREVENTION OF INVASIVE PULMONARY ASPERGILLOSIS IN IMMUNOSUPPRESSED OR NEUTROPENIC PATIENTS [J].
BEYER, J ;
SCHWARTZ, S ;
HEINEMANN, V ;
SIEGERT, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) :911-917
[6]   FUNGAL-INFECTIONS IN CANCER-PATIENTS - AN INTERNATIONAL AUTOPSY SURVEY [J].
BODEY, G ;
BUELTMANN, B ;
DUGUID, W ;
GIBBS, D ;
HANAK, H ;
HOTCHI, M ;
MALL, G ;
MARTINO, P ;
MEUNIER, F ;
MILLIKEN, S ;
NAOE, S ;
OKUDAIRA, M ;
SCEVOLA, D ;
VANTWOUT, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (02) :99-109
[7]   Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery [J].
Caillot, D ;
Casasnovas, O ;
Bernard, A ;
Couaillier, JF ;
Durand, C ;
Cuisenier, B ;
Solary, E ;
Piard, F ;
Petrella, T ;
Bonnin, A ;
Couillault, G ;
Dumas, M ;
Guy, H .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :139-147
[8]   CHEMOPROPHYLAXIS FOR PULMONARY ASPERGILLOSIS DURING INTENSIVE CHEMOTHERAPY [J].
COWIE, F ;
MELLER, ST ;
CUSHING, P ;
PINKERTON, R .
ARCHIVES OF DISEASE IN CHILDHOOD, 1994, 70 (02) :136-138
[9]   NIAID MYCOSES STUDY-GROUP MULTICENTER TRIAL OF ORAL ITRACONAZOLE THERAPY FOR INVASIVE ASPERGILLOSIS [J].
DENNING, DW ;
LEE, JY ;
HOSTETLER, JS ;
PAPPAS, P ;
KAUFFMAN, CA ;
DEWSNUP, DH ;
GALGIANI, JN ;
GRAYBILL, JR ;
SUGAR, AM ;
CATANZARO, A ;
GALLIS, H ;
PERFECT, JR ;
DOCKERY, B ;
DISMUKES, WE ;
STEVENS, DA .
AMERICAN JOURNAL OF MEDICINE, 1994, 97 (02) :135-144
[10]  
DENNING DW, 1990, REV INFECT DIS, V12, P1147